92

News

Danish biotech firm Symphogen enters multi-million dollar American partnership deal

TheCopenhagenPost
January 4th, 2016


This article is more than 8 years old.

The Danes will receive upfront payment and potential royalties for R&D efforts

The Danish biotech company Symphogen has entered into a strategic collaboration agreement with the US firm Baxalta that will see the Danes receive 175 million dollars (1.2 billion kroner) upfront, with the potential for future payments and royalties.

Symphogen specialises in antibody therapeutics for the treatment of cancer while Baxalta works with therapies for orphan diseases and underserved conditions in hematology, oncology and immunology.

Different strengths
According to the terms of the partnership, Symphogen will work on the development of six so-called novel immune checkpoint therapies in the treatment of rare diseases, whereafter Baxalta will have the exclusive option rights to commercialise the products worldwide.

Kirsten Drejer, the CEO of Symphogen, said the two parties brought different strengths to the table.

“Baxalta’s dedication to delivering transformative therapies and its global commercial presence make it an ideal strategic partner for Symphogen, as we complement Baxalta with R&D competencies within the immuno-oncology area,” she said.

“We look forward to providing Baxalta with innovative immuno-oncology product candidates under this broad collaboration.”


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”